Primitive metastazing bronchial carcinoid with long survival;Carcinoïde bronchique d'emblée multimétastatique et survie prolongée

Revue des Maladies Respiratoires

Volumn 24, Issue 1, 2007, Pages 63-68

  Bouvier, N ^a   Zengerling, V ^a   Halley, A ^a   Le Pennec, V ^a   Le Rochais, J P ^a   Madelaine, J ^a   Galateau Salle, F ^a   Bergot, E ^a   Zalcman, G ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

Carcinoid Tumor; Emission Tomography; Malignant Carcinoid Syndrome; Neoplasm Metastasis; Pentetreotide; Positron

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OSTREOSCAN; PENTETREOTIDE; PENTETREOTIDE IN 111; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATELECTASIS; BONE METASTASIS; BRONCHUS CARCINOID; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOID SYNDROME; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DYSPNEA; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER TUMOR; LOBECTOMY; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME;

EID: 33846833872     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(07)91013-x     Document Type: Article

References (12)

1. Hage R, De la Riviere AB, Seldenrijk CA, Van den Bosch JM : Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol 2003 ; 10 : 697-704
2. Filosso PL, Ruffini E, Oliaro A, Papalia E, Donati G, Rena O : Longterm survival of atypical bronchial carcinoids with liver metastases, treated with octreotide. Eur J Cardiothorac Surg 2002 ; 21 : 913-7.
3. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN : Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998 ; 22 : 934-44
4. Marty-Ane CH, Costes V, Pujol JL, Alauzen M, Baldet P, Mary H : Carcinoid tumors of the lung: do atypical features require aggressive management? Ann Thorac Surg 1995 ; 59 : 78-83.
5. Musi M, Carbone RG, Bertocchi C, Cantalupi DP, Michetti G, Pugliese C, Virotta G : Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy. Lung Cancer 1998 ; 22 : 97-102.
6. Granberg D, Sundin A, Janson ET, Öberg K, Skogseid B, Westlin JE : Octreoscan in patients with bronchial carcinoid tumours. Clin Endocrinol 2003 ; 59 : 793-9
7. Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC : Evaluation of primary pulmonary carcinoid tumors using FDG PET. Am J Roentgenol 1998 ; 170 : 1369-73.
8. Nguyen BD, Ram PC : Bronchopulmonary carcinoid tumor and related cervical vertebral metastasis with PET-positive and octreotide-negative scintigraphy. Clin Nucl Med 2006 ; 31 : 101-3.
9. Sun W, Lipsitz S, Catalano P, Mailliard JA, Haller DG, Eastern Cooperative Oncology Group : Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. J Clin Oncol 2005 ; 23 : 4897-904.
10. Ramage JK, Davies AHG, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A on behalf of UKNETwork for neuroendocrine tumours : Guidelines for the management of gastro-enteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005 ; 54 Suppl 4 : iv 1-16.
11. Kaltsas GA, Papadogias D, Makras P, Grossman AB : Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues. Endocr Relat Cancer 2005 ; 12 : 683-99.
12. Nobels FR, Kwekkeboom DJ, Coopmans W, Schoenmakers CH, Lindemans J, De Herder WW, Krenning EP, Bouillon R, Lamberts SW: Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab 1997 ; 82 : 2622-8.